Skip to main content
Print Save

BVF 300 BVF 300 (Diltiazem Hydrochloride Extended-Release (CD) 300 mg)

Pill with imprint BVF 300 BVF 300 is Green & White, Capsule-shape and has been identified as Diltiazem Hydrochloride Extended-Release (CD) 300 mg. It is supplied by Teva Pharmaceuticals USA.

Diltiazem is used in the treatment of atrial fibrillation; atrial flutter; angina pectoris prophylaxis; heart failure; high blood pressure and belongs to the drug classes calcium channel blocking agents, group IV antiarrhythmics. Risk cannot be ruled out during pregnancy. Diltiazem 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for BVF 300 BVF 300

Diltiazem hydrochloride extended-release (CD) 300 mg BVF 300 BVF 300
Diltiazem hydrochloride extended-release (CD) 300 mg BVF 300 BVF 300
Diltiazem hydrochloride extended-release (CD) 300 mg BVF 300 BVF 300

Diltiazem Hydrochloride Extended-Release (CD)

Imprint
BVF 300 BVF 300
Strength
300 mg
Color
Green & White
Size
22.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Calcium channel blocking agents, Group IV antiarrhythmics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
Inactive Ingredients
D&C Yellow No. 10, FD&C Green No. 3, gelatin, hypromelloses, magnesium stearate, microcrystalline cellulose, polysorbate 80, povidone, magnesium silicate, titanium dioxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00093-5119 (Discontinued) Teva Pharmaceuticals USA, Inc.
42291-0239 AvKare, Inc.
68682-0998 Oceanside Pharmaceuticals, Inc.
Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer